Investing Profile

John de Koning

VCInvestor
Partner at EQT Life Sciences
eqtgroup.com/about/people/joh...Amsterdam, Netherlands
Photo of John de Koning, Partner at EQT Life Sciences
Your Intro Paths to John de Koning

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find John de Koning on

cb
Current Investing Position
EQT Life Sciences Partner
Investment Range
$11.0M - $65.0M
Sweet Spot
$25.0M
Investments On Record
10
Current Fund Size
€260M

John de Koning is on these Sector & Stage Rankings

John de Koning's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
Tubulis
Series BMar 2024$140M
$210M
Co-investors: Sebastian Pünzeler (Coparion), Sofia Ioannidou (Andera Partners)
VarmX
Series BMay 2023$37M
Series BJul 2020$36M
$83M
Co-investors: Oscar Slotboom (BGV (BioGeneration Ventures)), Roel Bulthuis (INKEF Capital), Hermann Hauser (Amadeus Capital Partners)
eTheRNA immunotherapies
Series BAug 2022$39M
Series AMar 2016$27M
$66M
Visus Therapeutics
Debt FinancingAug 2021$20M
$61M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds), Tony Nguyen (RTW Investments)
Onward
Series UnknownApr 2021$32M
$51M
Co-investors: Caitlin Strandberg (Lerer Hippeau), Leo Polovets (Susa Ventures), Edward Lando (Pareto Holdings), Luis Valdich (Citi Ventures), Mark Joseph (Early Light Ventures), Natty Zola (Matchstick Ventures), Mark A. Johnson (TTV Capital), Dalton Caldwell (Y Combinator), Ryan Broshar (Matchstick Ventures), Jett McCandless
Merus
Series CApr 2015$79M
Series BOct 2013$42M
Series BJan 2010$30M
$150M
Co-investors: Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital), Jack Nielsen (Vivo Capital)